Policy Library

2 documents

FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development
Congressional Research Service · 2018-03-16 · Reports · 10,263 words · PDF available
The Federal Food, Drug, and Cosmetic Act (FFDCA) authorizes the Food and Drug Administration (FDA) to regulate the safety and effectiveness of drug products sold in the United States. The statutory st...
Prescription Drug User Fee Act (PDUFA): 2017 Reauthorization as PDUFA VI
Congressional Research Service · 2018-03-16 · Reports · 10,975 words · PDF available
The Prescription Drug User Fee Act (PDUFA, now called PDUFA I) was reauthorized as PDUFA VI by the Food and Drug Administration Reauthorization Act of 2017 (FDARA, P.L. 115-52). First passed by Congre...